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ABSTRACT Activation-inducedcytidinedeaminase(AID)mediatesthesomatichypermutation(SHM)ofimmunoglobulin(Ig)
variable(V)regionsthatisrequiredforthegenerationofantibodydiversityandfortheafﬁnitymaturationoftheantibodyre-
sponseagainstinfectiousagentsandtoxicsubstances.AIDpreferentiallytargetsWRC(W A/T,RA/G)hotspotmotifs,par-
ticularlyWGCWmotifsthatcreateoverlappinghotspotsonbothstrands.Inordertogainabetterunderstandingofthegenera-
tion of antibody diversity and to create a platform for the in vitro generation of afﬁnity-matured antibodies, we have established
asysteminvolvingrecombinase-mediatedcassetteexchange(RMCE)toreplacetheVregionanditsﬂankingsequences.This
makesitpossibletoeasilymanipulatethesequenceoftheIggenewithintheendogenousheavychainoftheRamoshuman
Burkitt’slymphomacellline.Hereweshowthatthenewlyintegratedwild-type(WT)VHregionsintroducedbyRMCEundergo
SHMsimilarlytonon-RMCE-modiﬁedRamoscells.Mostimportantly,wehaveshownthatintroducingaclusterofWGCWmo-
tifsintothecomplementarydeterminingregion2(CDR2)ofthehumanheavychainVregionsigniﬁcantlyraisedthemutation
frequencyandnumberofmutationspersequencecomparedtoWTcontrols.Thus,wehavedemonstratedanovelplatformin
RamoscellswherebywecaneasilyandquicklymanipulatetheendogenoushumanVHregiontofurtherexploretheregulation
andtargetingofSHM.Thisplatformwillbeusefulforgeneratinghumanantibodieswithchangesinafﬁnityandspeciﬁcity in
vitro.
IMPORTANCE Aneffectiveimmuneresponserequiresahighlydiverserepertoireofafﬁnity-maturedantibodies.Activation-
inducedcytidinedeaminase(AID)isrequiredforsomatichypermutation(SHM)ofimmunoglobulin(Ig)genes.Althougha
greatdealhasbeenlearnedabouttheregulationofAID,itremainsunclearhowitispreferentiallytargetedtoparticularmotifs,
tocertainlocationswithintheIggeneandnottootherhighlyexpressedgenesinthegerminalcenterBcell.Thisisanimportant
questionbecauseAIDishighlymutagenicandissometimesmistargetedtootherhighlyexpressedgenes,includingproto-
oncogenes,leadingtoBcelllymphomas.Herewedescribehowweutilizerecombinase-mediatedcassetteexchange(RMCE)to
modifythesequenceoftheendogenousheavychainlocusintheRamosBurkitt’slymphomacellline.Thisplatformcanbeused
toexploretheregulationandtargetingofSHMandtogeneratehumanantibodieswithchangesinafﬁnityandspeciﬁcity in
vitro.
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A
n effective immune response against infectious agents and
toxic substances requires the generation of a highly diverse
repertoire of antibodies that bind with strong afﬁnity. Initially
antibodies are diversiﬁed by the combinatorial rearrangement of
germ line immunoglobulin (Ig) variable (V), diversity (D), and
joining (J) gene segments to create the heavy (H) and light (L)
chain V regions. As B cells interact with antigen and differentiate
into antibody-secreting cells, these rearranged V regions undergo
a further diversiﬁcation process called somatic hypermutation
(SHM) to produce higher-afﬁnity antibodies that may also have
changesinﬁnespeciﬁcity(1).Whilemuchhasbeenlearnedabout
the generation of a diverse and high-afﬁnity repertoire, many de-
tails of how this process is regulated and targeted to antibody
genes are still poorly understood (2). To achieve a better under-
standing of this highly mutagenic process, it would be useful to
have new platforms to study the generation of antibody diversity
and the afﬁnity maturation of the immune response. Such plat-
forms would also be useful in generating better monoclonal anti-
bodies for solving many scientiﬁc questions and to diagnose and
treat disease.
Activation-induced cytidine deaminase (AID) is required for
and initiates SHM (3, 4) by deaminating dC residues of single-
stranded DNA (ssDNA) within transcription bubbles, creating a
guanine-uracil (G-U) mismatch. These mismatched bases are ei-
ther processed during replication, resulting in C-to-T transitions;
removed by uracil-DNA glycosylase (UNG) during short-patch
base excision repair (BER); or excised by mismatch repair
(MMR), where the excised DNA strand is resynthesized in an
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preferentially targets cytosines for deamination in WRC hot spot
(HS)motifs(7–10),butverylittleisknownaboutexactlyhowthis
targeting is achieved or why the V regions and not the C region
and most other non-Ig genes are not usually targeted (11–13).
One way to examine the mechanisms and identify the factors re-
sponsibleforthepreferentialtargetingofAIDwouldbetochange
the sequences in the Ig V region and its immediate ﬂanking se-
quencesandregulatoryregions.Thisispreferablydonewithinthe
endogenouslocus,sinceallofthecis-actingsequencesrequiredfor
this process have yet to be determined. Antibody-forming B cell
lines in tissue culture allow the examination of multiple different
engineered versions of parts of the Ig gene, but such experiments
requiretherepeatedreplacementofthewild-type(WT)Iggeneby
themodiﬁedHorLchaingenes(14).Currently,thisismostoften
done using the DT40 cell line, which has a high frequency of ho-
mologous recombination (15, 16). However, DT40 is a chicken B
cell line where the somatic V region mutation process coexists
with gene conversion. Even though the competition between
SHM and gene conversion can be overcome using genetically
modiﬁed versions of DT40 (17–19), these cells do not express the
secondphaseofSHMinvolvingBERandMMRthatisresponsible
fortheacquisitionoflargenumbersofmutationsinA-Tresidues,
and in this and probably other ways, the mutational process in
DT40 cells differs from that which occurs in mouse and human B
cells (20, 21).
The frequency of homologous recombination in the IgH locus
in centroblast-like human Epstein-Barr virus-negative (EBV)
Burkitt’slymphomacelllinesisquitehigh(22),butthesecelllines
would be even more useful if the replacements could be restricted
to the rearranged IgH chain locus in a way that favored the re-
placement of only the endogenous gene and the insertion of the
transfected gene in the correct orientation. Here we describe the
use of the recombinase-mediated cassette exchange (RMCE)
strategy (23–26) as a technique that can be used to easily manip-
ulate the sequence of the Ig gene within the endogenous locus of
theRamoshumanBurkitt’slymphomaBcellline.Ramoscellsare
an excellent cell line for this system because they constitutively
expressAIDandundergoSHMintissueculture(27–30),areeasily
transfectable, have only one rearranged IgH chain V region, ex-
press large amounts of surface IgM, and secrete only small
amounts of antibody. It has already been shown that these prop-
ertiesallowtheuseofﬂuorescence-activatedcellsortingofRamos
cells to sequentially select for rare cells, making variants of the
endogenous Ramos antibody that have a higher afﬁnity and
changes in speciﬁcity and thus can mimic the afﬁnity maturation
ofnormalhumanantibodies(31).ThissuggeststhatiftheRamos
IgH V regions could be readily replaced by other V regions, this
platform could be used to afﬁnity mature and change the ﬁne
speciﬁcity of many different monoclonal antibodies.
HerewedescribehowtouseRMCEtoreplacetheendogenous
IgH V region, and we show that the newly inserted wild-type V
region undergoes SHM at approximately the same rate and with
the same characteristics as that in the original wild-type Ramos
cells. By engineering a replacement construct with multiple clon-
ing sites, we can insert any V region in place of the endogenous
IgHVregionandeasilymanipulatethesequenceoftheVregionas
well as surrounding cis regulatory sequences at the endogenous
locus.Wealsodemonstratethatwecanincreasetherelativelylow
spontaneous rate of mutation seen in all cultured cells (32) by
introducingaclusterofhotspotsintothehighlymutablecomple-
mentary determining region 2 (CDR2) of the V region without
changingthedistributionorcharacteristicsofthemutationalpro-
cess. This indicates that the Ramos cells provide a useful platform
for examining the role of the V region sequence environment and
of cis-acting elements and for afﬁnity maturing of human anti-
bodies to any antigen.
RESULTS
Replacing the endogenous IgH VDJ and ﬂanking regions of
Ramos cells with Hyg-TK. To establish RMCE (23) in Ramos
cells, we created a number of constructs that could be homolo-
gously recombined into the endogenous H chain locus. First, a
targeting construct (Fig. 1A) was generated that contained 2.2 kb
of sequence 5= to the promoter of the endogenous rearranged VH
4–34 gene (5= homologous arm), a lox site (lox), the hygromycin
and thymidine kinase resistance genes (Hyg-TK) driven by a cy-
tomegalovirus (CMV) promoter, a second lox (lox) site that dif-
fers from the ﬁrst lox site to facilitate directional integration, and
5.8kbofsequences3=totheswitchregionthatincludeallofthe
 constant region and the membrane and secretory exons (3=
homologous arm). When the targeting construct was transfected
into surface IgM-positive Ramos cells, ~2% (5/235) of the trans-
fected cells were hygromycin resistant and surface IgM negative.
Since they had lost their surface IgM, it was likely that they had
undergone homologous replacement of the H chain V, E,o rS 
(Fig.1A).Toconﬁrmthis,allﬁveoftheindependentlytransfected
IgM hygromycin-resistant clones were analyzed by Southern
analysis and compared to the original unmodiﬁed Ramos clone
(labeled “C” for control) (Fig. 1B). This revealed that the produc-
tive endogenous IgH gene had been disrupted while the other
Ramos endogenous IgM gene that had previously undergone
translocationwithMycwasstillpresent.UsingprimerP1,located
outside the targeting construct, and primer P2, located within the
targetingconstruct(Fig.1A),PCRanalysisofgenomicDNAfrom
each of the 5 independently transfected clones further conﬁrmed
that the Hyg-TK gene was present and in the correct orientation
(Fig. 1C). The presence of the Hyg-TK gene and the loss of the
productivegeneestablishedthattheHyg-TKgenehadhomolo-
gouslyrecombinedintotheendogenousproductiveHchainlocus
and that the targeting construct was in the correct orientation.
Cre-mediatedreplacementoftheHyg-TKwiththeRamosV
region. Next, we transfected a wild-type replacement construct
containinglox(2L)-VDJ-E-S-lox(L3)(WTA)(Fig.2)intothe
Hyg-TK-expressing cells (Hyg-TK) along with a Cre expression
plasmid and allowed it to recombine at the lox sites (primary
replacement of Hyg-TK). The TK gene was present so that we
could have counterselected with ganciclovir for clones in which
theHyg-TKwasreplaced(23).However,wefoundthattheRamos
cellswereverysensitivetoganciclovir,anditwasdifﬁculttoﬁnda
dose that did not kill some of the TK-negative cells. Since in this
case the clones that had successfully integrated the replacement
vector expressed surface IgM, recovering IgM cells by
ﬂuorescence-activated cell sorting provided an easy and reliable
counterselection in which virtually all of the counterselected cells
expressed the replacement vector. We therefore elected to isolate
integratedclonesbysortingforIgMandcloningIgMcellsinsoft
agar.Theisolationandsubsequentcharacterization(seebelow)of
these IgM cells demonstrated that the endogenous H chain gene
could be easily restored in Ramos cells.
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RMCE clones could undergo a second round of replacement, we
transfected still another replacement construct that contains a
C-to-Gmutationatposition237locatedwithinframework2,cre-
ating a nonsense mutation (WT B) (Fig. 2 and 3A) into the WT A
clones along with a Cre expression plasmid and allowed it to re-
combine at the lox sites. In this case, the successfully integrated
clonesdidnotexpresssurfaceIgMduetotheirnonsensecodon,so
we recovered IgM cells by ﬂuorescence-activated cell sorting.
The successful replacement of the WT A insert by WT B demon-
strated that a secondary replacement of the endogenous H chain
genecouldbeachievedinRamoscellsthathadalreadyundergone
one replacement. Independently derived WT A and WT B clones
were each subcloned, and the WT A and B subclones were found
to express similar levels of AID transcripts (Fig. 3B).
RMCEclonesundergoSHMwithWTfrequencyandcharac-
teristics. To conﬁrm that cassette exchange would allow a re-
placed gene to function like the WT gene, we grew constitutively
mutating Ramos clones with the newly inserted V regions for
1.5 months to accumulate a sufﬁcient number of mutations and
sequencedrandomVregionsaswehavedoneinthepast(30,33).
Ramos cells have only one rearranged V region, allowing us to
amplify only the V region that was successfully integrated in the
correctlocationusingprimersthatannealupstreamoftheﬁrstlox
site and within JH6 (Fig. 3A, primers P3 and P4). Since it is pos-
sible that some mutations could have arisen during the cassette
exchange (34), cells were collected immediately following sub-
cloning and their V regions were sequenced and found to not
containnewmutations.Additionally,onlyuniquemutationswere
scored in order to eliminate the possibility that “founder muta-
tions” that arose before the start of the experiment would bias the
results, although this results in the loss of some mutations which
occur recurrently in hot spots and thus leads to an underestimate
of the frequency of mutation. Sequence analysis of random V re-
gions (between primers P3 and P4 shown in Fig. 3A; also Table 1)
from the progeny of Ramos subclones WT A and WT B undergo-
ing constitutive SHM revealed no signiﬁcant differences (P 
0.6109, 2 test) in the frequency of unique mutations between the
two sequentially replaced V regions (Fig. 3C; Table 1). This
showed that, as reported in other systems (35), the small amount
FIG1 Schematic of the recombinase-mediated cassette exchange strategy. (A) Homologous recombination to create the Hyg-TK Ramos cell line. A schematic
of the productive endogenous IgH allele includes the leader exon (L), the variable region (VDJ), E,S , and C. The 5= and 3= homologous arms, the lox sites,
and the location of the Hyg-TK gene are depicted in the targeting construct. (B) Southern blot of 5 independently isolated Hyg-TK RMCE clones and a control
(lane C) IgM wild-type non-RMCE Ramos clone. DNA was digested with NotI and NsiI, shown in panel A, and hybridized with a C probe depicted by the
black diagonal line in panel A. (C) PCR analysis using genomic DNA of the same clones described in panel B using primers P1 and P2 shown in panel A.
FIG2 Schematic of the Cre-mediated recombination to create the replaced IgH at the endogenous locus. The pentagon represents the addition of Cre, and the
arrows demonstrate the transfection of WT A to create the primary replacement and the transfection of WT B to create the secondary replacement. The asterisk
indicates the C-to-G mutation within VDJ of WT B.
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WT B that was close to the promoter did not affect the rate of V
regionmutation(Fig.3C).ThenewlyinsertedWTAandWTBV
regionsunderwentasimilarfrequencyofmutationasdidtheorig-
inal parental wild-type Ramos cells (29, 30, 33) that were used to
create the RMCE clones.
To determine whether the RMCE process mistargets AID to
the regions of the Ig gene ﬂanking V which normally do not un-
dergo SHM (11, 12, 36), we have also sequenced the promoter
regionfromthe2Lsitetotheleaderexon(betweenprimersP3and
P8) as well as the functional C (37) from the CH1 exon to the
CH2 intron (Fig. 3A, between primers P5 and P6). Although we
detected a few mutations (0.8  104 to 1.3  104 mutations/
bp) in the promoter and constant regions (Fig. 3C; Table 1), the
mutation frequency was statistically signiﬁcantly lower than the
frequencyofVregionmutations(Vversuspromoter,P0.002;V
versus C, P  0.03) and these mutations were not in AID hot
spots, suggesting that these low-frequency mutations likely arose
from PCR error (33). This is in contrast to the V region, where
39%ofthemutationsinWTRMCEcloneswereinWRCY/RGYW
AID hot spot motifs, similar to the original parental wild-type
Ramos cells (29).
Furthermore, Ramos RMCE clones showed characteristics of
the mutations in the V regions similar to those of the parental
wild-typeRamoscellsinthat~85to90%ofthemutationswerein
G-C residues (see Table S1 in the supplemental material). The
FIG 3 Insertion of a cluster of hot spots into the endogenous heavy chain gene of Ramos cells increases V region mutation. (A) Schematic of the replaced IgH
locus with primer pairs used for ampliﬁcation and sequencing indicated by arrows (P3 to P8). (B) Relative AID transcript levels in the various subclones shown
inthebargraphwithstandarddeviations.(C)AbargraphshowingthefrequenciesofmutationsdepictedinTable1fromthepromoter,V,andconstantregions.
Error bars represent the standard deviations between 2 clones. (D) Pie charts representing the number of mutations per sequence; the number of sequences
analyzed is depicted in the center of each circle.
TABLE 1 Mutations from WT and HS cell linesa
Region Clone No. of unique mutations Total bp sequenced Frequency (104)
Promoter WT A 7 63,392 1.1
WT B 6 75,278 0.8
HS A 4 63,958 0.8
HS B 6 45,846 1.3
VH WT A 17 58,166 2.9
WT B 14 61,372 2.3
HS A 57 62,288 9.2
HS B 33 54,960 6.0
C WT A 6 46,848 1.3
WT B 7 58,560 1.2
HS A 7 53,436 1.3
HS B 6 43,920 1.4
a The promoter region was ampliﬁed using primers P3 and P4 and sequenced using primer P8. This region corresponds to a 566-bp region from the 2L lox site to the leader exon.
The V region was ampliﬁed using primers P3 and P4 and sequenced using primer P7. This region corresponds to a 458-bp region from the leader intron to the end of JH6. The
functional C was ampliﬁed using primers P5 and P6 and sequenced using primer P5. This region corresponds to a 732-bp region from the CH1 exon to the CH2 intron.
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RMCE-derived Ramos mutations, since the moving average of
mutation frequencies (see Materials and Methods) has a correla-
tion of 0.79 (P  2  1016).
Insertionofaclusterofhotspotsintotheendogenousheavy
chain gene of Ramos cells increases the frequency of mutation
throughouttheVregion.Asinotherculturedmouseandhuman
Bcelllines(32),theoverallfrequencyofmutationintheVregions
was 2  104 to 4  104, which is only 2- to 3-fold greater than
the PCR error (Table 1) and ~10-fold lower than the frequencies
of mutation that are seen in vivo in germinal center B cells (2, 38).
Asaconsequence,onlyasmallpercentageofrandomlysequenced
RamosVregionscontainnewuniquemutations(Fig.3D),andin
the V regions that have undergone SHM, the number of new mu-
tations that accumulate even after 1 to 3 months, while orders of
magnitudehigherthanthatinnon-Iggenes,issmallcomparedto
the PCR error (Fig. 3; Table 1). We therefore explored ways to
increase the frequency of mutation in the Ramos cell line so as to
makeitmoreusefulasatooltoexploretheeffectofchangesinthe
local sequence environment and of cis-acting sequences on the
distribution and characteristics of mutations in the V region and
to generate better antibodies more quickly.
An extension of the WRC motif, the WGCW motif, particu-
larlytheAGCTvariantofthatmotif,hasbeendemonstratedtobe
highly susceptible to AID mutation (9, 10, 39–43). The WGCW
motif represents an overlapping hot spot (a hot spot on both the
top and bottom strands) within which the adjacent C’s on oppo-
sitestrandscouldbetargetedformutation.Thismotifisenriched
inmammalianswitchregions(44)andhasbeenidentiﬁedasasite
of focusing of mutations in vivo in the absence of repair (41–43).
Withthethoughtthataclusterofhotspotscouldactasanentryor
activation site for AID, we engineered a cluster of 4 WGCW hot
spots within the CDR2 of the Ramos IgH V gene to create 8 total
hot spots within a 20-bp stretch on both the upper and lower
strands(Fig.3A)withoutchangingtheaminoacidsequenceofthe
VH region. This V region with its cluster of HSs was introduced
into two different Ramos subclones by RMCE (HS A and HS B in
Fig. 3), and the frequency of mutation was determined by se-
quencing (Fig. 3; Table 1). These HS cluster clones had a statisti-
cally signiﬁcant ~2- to 4-fold increase in the frequency of unique
mutationscomparedtotheWTRMCEcontrols(Fig.3C;Table1)
(WT A/B versus HS A, P  0.0001; WT A/B versus HS B, P 
0.0009;HSAversusHSB,P0.0664).Thiswasassociatedwitha
larger number of mutated V regions, and there were more V re-
gions with greater than 1 mutation per V (Fig. 3D) (WT A/B
versusHSA,P0.0002;WTA/BversusHSB,P0.0079).While
the overall frequency of unique mutations in the V regions with
the HS cluster was increased, the characteristics of the mutations
in the V regions with the HS cluster resemble the WT in that ~85
to90%ofthemutationswereinG-Cresidues(seeTableS1inthe
supplemental material). While it was possible that the AID-
induced mutations could have been concentrated in and around
theHScluster,thisdidnotoccur,andthemutationsweredistrib-
uted throughout the V region in a pattern that was similar to that
of the WT RMCE clones (Fig. 4; see also Fig. S1). We repeated the
moving average analysis (see Materials and Methods) comparing
the distribution of mutations in the HS cluster and WT V regions
andagainfoundahighlysigniﬁcantpositivecorrelation(r0.52,
P21016).Thus,wehavedemonstratedthattheinsertionof
a V region by RMCE in Ramos cells containing a cluster of over-
lapping hot spots increases the frequency of mutation without
changing their characteristics or distribution.
FIG 4 Distribution of mutations in WT and HS clones. Distribution of total mutations in the 458-bp VDJ region of HS A and B clones compared to WT
A. The red line indicates the boundary of the hot spot cluster. Some sequences were dominated by a single highly mutated site which was removed from
the analysis and replaced by the blue line in order to display the results on the same y axis scale. The black boxes represent the WGCW motifs. In order
to increase the number of mutations examined, additional sequences from WT A and HS A and B subclones not shown in the previous ﬁgures and Table
1 were added to this ﬁgure.
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WhenAIDandIggenesareintroducedintonon-BcellsandBcell
lines, the transfected Ig genes will undergo AID-induced muta-
tions, especially if they are surrounded by Ig regulatory elements
and if AID is overexpressed (29, 33). In addition, transfected
non-Iggenes,includingAIDitself,canundergoAID-inducedmu-
tations in B and non-B cells (33). Perhaps one of the most useful
examples of this was the generation of red ﬂuorescent protein
(RFP) molecules with new and useful properties when RFP was
introduced into Ramos cells that were constitutively expressing
AID (45). These transfected cell systems have made it possible to
study some aspects of the regulation of AID targeting and to
changethepropertiesofIgandnon-Igproteins.Studieswithmu-
tant mice and biochemical analysis have revealed some of the as-
sociated proteins that contribute to higher mutation rates in Ig
genes (46–50). Although some cis-acting sequences have been
shown to have a role in targeting AID to antibody V regions (15,
51) and structure-function studies with AID have revealed the
parts of the enzyme that are responsible for recognizing hot spot
motifs(52–55),muchremainstobelearnedabouttheseaspectsof
the mutational process.
Tofacilitatesuchstudies,wehavemodiﬁedtheRamoshuman
Burkitt’s lymphoma cell line so that the structure of the IgH V
regions and its immediate ﬂanking sequences can be readily and
repeatedly modiﬁed using RMCE. In this study, we have shown
that once the endogenous VH and its ﬂanking regulatory regions
are replaced by the RMCE targeting lox-Hyg-TK-lox gene, mod-
iﬁed VH genes can be readily inserted in one copy in the proper
orientation into the IgH locus. Ectopic insertions were not de-
tected. In addition, we found that the replaced wild-type VH re-
gions mutated at the same frequencies and with the same charac-
teristics and distribution as did the endogenous Ramos VH
regions. In addition to the various modiﬁcations of the endoge-
nousRamos4–34VHregionsdescribedhere,twootherhumanV
regionshavebeenintroducedbyRMCEandfoundtomutatewith
frequencies similar to those of the WT 4–34 V region. In order to
use this system to afﬁnity mature unrelated human antibodies, it
will also be necessary to replace the L chain. While this could be
done by establishing a separate RMCE system with different drug
markersforthelightchain,wehavefoundthatasimplerwaytodo
this is to identify subclones of Ramos cells that have the IgH
RMCE vector and have lost the ability to make the endogenous L
chains.TransfectedLchainsinectopiclocationsdoundergoAID-
inducedmutations,thusallowingthemutationofboththeHand
L chains if that is required for afﬁnity maturation (data not
shown).
A signiﬁcant problem with using the Ramos system and other
culturedBcellsystemseithertoexaminethemechanismsofSHM
ortomakebetterantibodiesorotherproteinsisthatthefrequency
of AID-induced mutations, while still high compared to the mu-
tation rate throughout the genome, is still ~10-fold lower than
that which is observed in vivo and only a fewfold higher than the
PCR error rate. While this can be overcome to some degree by
overexpressing AID, this also causes targeting of the C region and
other highly expressed genes such as AID itself (33, 36), making it
difﬁcult to study the preferential targeting of AID to antibody V
regions. Mutant AID molecules with increased activity increase
the mutation rate but also tend to decrease the speciﬁc targeting
and the viability of the host cell, presumably due to an increase in
AID mutations in critical non-Ig genes (55).
Here we have shown that we can avoid these problems by in-
creasing the frequency of AID-induced mutations in the V region
by introducing a cluster of WGCW AID hot spots that lead to
overlapping hot spots in the CDR2 of the VH region. This in-
creasedthemutationrate2-to4-foldsothatitbeginstoapproach
the in vivo frequency of mutation without signiﬁcantly changing
the overall targeting, characteristics, and distribution of muta-
tions within the V region. We conﬁrmed that the increase in mu-
tationwasrestrictedtotheVHregionthatcontainedtheclusterof
hot spots by sequencing the endogenous L chain genes in Ramos
cells (37) and showing that the frequencies of mutation in the L
chains were similar in the WT and HS A and B clones (data not
shown). The WGCW motif has been shown to be more highly
targeted for mutation in vivo (9, 10, 39–43, 56). Because of the
high frequency of mutations at such sites within the mouse JH4
intron and S region in the absence of repair (41–43, 57, 58) and
inhumanVregions(10,59),ithasbeensuggestedthatitcouldbe
a potential site for the entry of AID (40, 42). Since AID is a very
inefﬁcient enzyme (60, 61), it is possible that AID accesses the V
region elsewhere but is preferentially activated at this motif to
initiate the process of mutation. Since AID can form multimeric
complexes (62–64), it is also possible that it could preferentially
associate with both strands of DNA where there are overlapping
hot spots and promote multiple deamination reactions (40, 64).
Whatevertheexplanation,itissurprisingthattherewasnotalocal
increase in mutations in and around the hot spot cluster. Of 11
different subclones expressing the cluster of hot spots, only one
revealedanincreaseofmutationsintheregionofthecluster(data
not shown), and further experiments will be required to deter-
mine the true frequency of such clones and the mechanism re-
sponsible for the increased focusing of mutation with the hope
thatsuchstudieswillrevealnewinformationonthetargetingand
activation of AID in vivo. While this work was in progress, RMCE
was also used in mouse CH12 cells to study detailed sequence
requirements for targeting AID to mouse Ig switch regions to
mediate class switch recombination (26). These authors con-
cluded that it was the overlapping nature of the WGCW motif,
rather than the palindromic characteristics of some representa-
tives of the motif, that increased the likelihood of mutations and
subsequent double-stranded DNA breaks in switch regions.
Here we present a novel platform for the modiﬁcation of the
immunoglobulin V region using RMCE in Ramos cells. We have
shown here that inserting a cluster of overlapping hot spots in the
H chain V region increases the rate of mutation without affecting
the characteristics or distribution of those mutations, illustrating
how this system will be useful in exploring the regulation and
restriction of V region mutations. Since we can also insert new L
chains and the Ramos cells have been shown to switch at a low
frequency from IgM to IgG expression (65), this system will be
useful for the afﬁnity maturation of human monoclonal antibod-
ies.
MATERIALS AND METHODS
Cell lines and culture conditions. The Ramos Burkitt’s lymphoma cell
line was obtained from Hilda Ye (Albert Einstein College of Medicine,
Bronx,NY)andgrowninIscove’smodiﬁedDulbecco’smedium(IMDM;
BioWhittaker, Walkersville, MD) supplemented with 10% fetal bovine
serum (Atlanta Biologicals, Lawrenceville, GA) and 100 U/ml penicillin-
Baughn et al.
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formed as previously described (30). An IgM subclone of Ramos 6 (30),
Ramos 6.25 subclone 8 (6.25), was used as the parental clone for the
RMCE system.
RMCE plasmids. Details of the construction of the targeting and re-
placement constructs are located in the supplemental material (see
Text S1). Brieﬂy, for the targeting construct, the 5= and 3= homologous
arms were constructed by PCR ampliﬁcation from Ramos clone 6
genomic DNA and the lox and Hyg-TK segments were cloned from the
pCR4-TOPO-2L-Hyg-TK-L3 vector (Eric Bouhassira, Albert Einstein
College of Medicine, Bronx, NY). Hygromycin-resistant IgM LC
Ramos cells transfected with the targeting construct were screened for
integrationofthetargetingconstructbyPCRusingthefollowingprimers:
P1, 5= CTATGTGGCGAAAGGCAATCTATC 3=, which binds upstream
ofthe5=arm,andP2,5=GAACTCCATATATGGGCTATGAAC3=,which
bindswithintheCMVpromoteroftheHyg-TKgene.Forthereplacement
constructs,thepUCVDJ1ES(WTA)replacementwascreatedfroma
seriesofintermediateplasmidsdetailedinthesupplementalmaterials(see
Text S1). The pUC VDJ4-1 ES (WT B) and pUC VDJ hot spot ES
(HS) plasmids were created by site-directed mutagenesis by PCR ampli-
ﬁcation of pUC VDJ1 ES (WT A) as described in the supplemental
material (see Text S1).
Transfectionconditions.Ramoscellswereelectroporatedwitheither
2 g of the “targeting construct” or 12.5 g of each “replacement con-
struct”alongwith3.2gofCreusingtheNucleofectorII(Lonza,Amaxa,
Cologne, Germany) and Nucleofection (Lonza) kits. pBS 185 CMV-Cre
was a gift from Eric Bouhassira (Albert Einstein College of Medicine,
Bronx, NY) and was originally obtained from Clontech (Palo Alto, CA).
Ramos RMCE clones were selected using 0.6 mg/ml of hygromycin (Cal-
biochem).
Fluorescenceanalysisandsorting.Ramoscellswerestainedwithgoat
anti-human IgM-ﬂuorescein isothiocyanate (FITC) (Southern Biotech-
nology Associates, Birmingham, AL) and analyzed using the FACScan
(Becton Dickinson, Franklin Lakes, NJ) cell sorter. For ﬂuorescence-
activatedcellsortingexperiments,atleast2107cellswereused,stained
as described above, and sorted using a FACSAria (Becton Dickinson) cell
sorter.
Southern blotting. Genomic DNA from hygromycin-resistant IgM
LC Ramos clones (Hyg-TK) was digested with NotI and NsiI, and the
DNA fragments were separated on a 0.7% agarose gel, transferred to a
Hybond N nylon membrane (GE Healthcare, Amersham Biosciences,
Piscataway,NJ)in20SSC(3MNaClplus300mMsodiumcitrate),and
UVcross-linkedtothemembrane.ACprobecontainingthemajorityof
exons1to3wasgeneratedbydigestingthe3=homologousarmDNAwith
SbfI and HincII, labeled with [-32P]CTP, hybridized to the blot at 65°C
for 2 h, and visualized by autoradiography. Clones containing the target-
ing vector correctly integrated at the functional C allele produced a
~6.4-kb band as well as a ~7.5-kb band that represented the nonfunc-
tional C allele. Parental clones RMCE 1 and RMCE 3 (Fig. 1B and C)
were thus identiﬁed and used in this study. No signiﬁcant difference in
mutationfrequencywasdetectedwheneithertheRMCE1ortheRMCE3
clone was used.
PCR ampliﬁcation, cloning, and sequencing. Genomic DNA was
prepared as reported previously (30). The V and C region from Ramos
clones were ampliﬁed using Pfu Turbo Cx Hotstart polymerase from
genomic DNA by using 30 cycles of 95°C for 30 s, 60°C for V region or
66°CforCfor30s,and72°Cfor1min.PrimersfortheVregionwereP3,
5= TGTCTTCAGATCAGCAGCCTAAAG 3= (5= primer), and P4, 5= CAT
TCTTACCTGAGGAGACGGTG 3= (3= primer), and for the C region
wereP5,5=GCATCCGCCCCAACCCTTTTC3=(5=primer),andP6,5=G
CGAATGCCAGACCCGAGTG 3= (3= primer). PCR products were mod-
iﬁed by A-tailing using Taq polymerase and cloned using the pGEM-T
vector system. Minipreparations were prepared using the Montage Plas-
mid MiniprepHTS 96 kit (Millipore, Billerica, MA) and sequenced using
theABI3730DNAanalyzer(AppliedBiosystems,Carlsbad,CA).Primers
used for sequencing were the following: V region, P7, 5= GCACAAGAAC
ATGAAACACC 3=; IgH promoter region, P8, 5= GGACCCCTGTGAAC
AGAAAA 3=;C , P5, as described above. The functional C allele was
distinguished from the nonfunctional allele as described previously (37).
DNA was analyzed using SeqMan (DNAStar, Madison, WI), and statisti-
cal analysis was performed using a chi-square test.
Extraction of RNA and quantitative real-time RT-PCR. RNA was
extracted as reported previously (30). Five micrograms of RNA was re-
verse transcribed using the Superscript III ﬁrst-strand synthesis system
(Invitrogen).Quantitativereal-timePCRofcDNAwasperformedintrip-
licate using the DNA Engine Opticon 2 cycler (MJ Research, Waltham,
MA)andQuantiTectSYBRGreen(Qiagen)byusing40cyclesof94°Cfor
15 s, 60°C for 30 s, and 72°C for 30 s. The following primers were used:
IgM,5=GACACGTCCAAGAAACAGC3=(5=primer)and5=GCCCTAG
TAATAACTCTCGC 3= (3= primer); AID, 5= CTTCGCAATAAGAACGG
CTG3=(5=primer)and5=GAGGTGAACCAGGTGACGC3=(3=primer);
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 5= CTGCGACC
GCCCCCGAACCG3=(5=primer)and5=TACCCTGCCCCCATACGAC
TGCAAAGACC 3= (3= primer). Data were analyzed using the Opticon
Monitor 3 program (MJ Research), and relative fold changes in cDNA
levelswerecalculatedusingthethresholdcycle(2CT)methodwiththe
GAPDH reference gene as normalization (66).
Moving average analysis. Because the mutation frequency in Ramos
cells is relatively low, a direct site-by-site comparison of mutation fre-
quencies is inappropriate. We therefore compared the overall patterns of
unique mutation frequencies using a moving average, i.e., the mean mu-
tationfrequencywithinaslidingwindowoflength100alongthelengthof
the sequence. In each case, we also tested with shorter window lengths of
80and60withsimilarresults.Wethencalculatedthecorrelationbetween
the two moving averages. When comparing data sets with nonidentical
germ line sequences, we excluded any sites that were not shared between
the two germ line sequences.
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